GLP-2
Research-grade GLP-2, lyophilized powder, >99% HPLC purity. Third-party tested with a certificate of analysis per lot.
| Purity | >99% (HPLC) |
|---|
| Molecular formula | C225H348N48O68 |
|---|
| CAS | 2023788-19-2 |
|---|
| Form | Lyophilized powder |
|---|
| Sizes | 10 mg, 30 mg |
|---|
Certificate of Analysis for GLP-2
Research reference
Tirzepatide (development code LY3298176) is a fatty-acid-modified peptide with dual GIP and GLP-1 receptor agonist activity, built on a GIP peptide backbone conjugated to a C20 fatty acid moiety. Binding affinity and cAMP-accumulation potency have been characterized in HEK 293 cells transfected with the human GIP and GLP-1 receptors. Signaling studies describe greater receptor engagement at GIP than GLP-1, and bias at the GLP-1 receptor favoring cAMP generation over β-arrestin recruitment, with weaker receptor internalization than native GLP-1. Research use only. Not for human consumption.
Literature
All products are sold strictly for laboratory and research use only. Not for human or animal consumption, ingestion, injection, or diagnostic use. Not intended to diagnose, treat, cure, or prevent any disease.
